Sign Up for a Free Account
  • Updated 09.04.2021
  • Released 11.13.2003
  • Expires For CME 09.04.2024



Historical note and terminology

Most of the drugs for the treatment of attention-deficit/hyperactivity disorder (ADHD) have been CNS stimulants in the past. Originally called tomoxetine, the drug's name was changed to atomoxetine to avoid any potential confusion with the anticancer drug tamoxifen that might lead to dispensing errors. Atomoxetine is not a controlled substance in the United States. It is the first nonstimulant approved by the FDA for the treatment of ADHD in children, adolescents, and adults.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125